However, XZP treatment significantly reduced the values of serum TRACP5b and CIPT but also decreased the levels of serum PINP and BAP in rats, further supporting that aberrant activation of osteoclasts enhanced the activity of osteoblasts in the bone cancer rats. The gene discussed is ACP5; the disease is bone cancer.